share_log

Why Reata Pharmaceuticals Shares Are Trading Higher By 140%; Here Are 20 Stocks Moving Premarket

Benzinga ·  Mar 1, 2023 21:00

Gainers

  • Reata Pharmaceuticals Inc (NASDAQ:RETA) rose 140.8% to $75.06 in pre-market trading after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia.
  • OncoSec Medical Incorporated (NASDAQ:ONCS) rose 75.9% to $1.90 in pre-market trading after the company requests withdrawal of registration statement, The company said it has opted not to pursue offering thereby at this time.
  • Lionheart III Corp (NASDAQ:LION) shares rose 56.2% to $22.80 in pre-market trading after jumping around 98% on Tuesday.
  • China Pharma Holdings Inc (NASDAQ:CPHI) rose 20.8% to $0.081 in pre-market trading. China Pharma recently announced a 1-for-10 reverse stock split.
  • Helbiz Inc (NASDAQ:HLBZ) rose 19.1% to $0.17 in pre-market trading after gaining over 21% on Tuesday.
  • Sarepta Therapeutics Inc (NASDAQ:SRPT) rose 17% to $142.90 in pre-market trading after the company reported better-than-expected Q4 results.
  • Landos Biopharma Inc (NASDAQ:LABP) shares rose 14.9% to $0.43 in pre-market trading. Landos Biopharma announced transfer of LANCL portfolio, including Omilancor, LABP-104 and LABP-111 to Landos' founder.
  • China SXT Pharmaceuticals Inc (NASDAQ:SXTC) rose 14.7% to $0.45 in pre-market trading after gaining over 3% on Tuesday.
  • Cerevel Therapeutics Holdings Inc (NASDAQ:CERE) rose 9.7% to $29.30 in pre-market trading. Cerevel Therapeutics recently posted a narrower-than-expected quarterly loss.
  • Bilibili Inc - ADR (NASDAQ:BILI) shares rose 8.8% to $21.00 in pre-market trading after dropping over 3% on Tuesday.

Losers

  • OKYO Pharma (NASDAQ:OKYO) fell 24.2% to $1.69 in pre-market. US Customs cleared OKYO Pharma's GMP packaged OK-101 drug for Phase 2 clinical trial for treating dry eye disease.
  • Novavax Inc (NASDAQ:NVAX) fell 24% to $7.04 in pre-market trading after the company reported worse-than-expected Q4 results and said substantial doubt exists regarding its ability to continue as a going concern.
  • Marqeta Inc (NASDAQ:MQ) fell 19.1% to $4.69 in pre-market trading after the company reported fourth-quarter results and issued guidance for slowing growth.
  • Beamr Imaging Ltd. (NASDAQ:BMR) shares fell 18.6% to $2.97 in pre-market trading. Beamr Imaging priced its initial public offering of 1,950,000 at a public offering price of $4.00 per share.
  • Obseva SA (NASDAQ:OBSV) shares dropped 15.2% to $0.12 in pre-market trading after jumping 43% on Tuesday. ObsEva recently announced strategic reorganization to consolidate operations in Switzerland.
  • Brightspire Capital Inc (NYSE:BRSP) fell 14.4% to $6.32 in pre-market trading after the company announced an offering of 30,358,213 shares by DigitalBridge Group, Inc.
  • Performance Shipping Inc (NASDAQ:PSHG) fell 13% to $2.34 in pre-market trading. Performance Shipping announced termination of at-the-market offering.
  • Grove Collaborative Holdings Inc (NYSE:GROV) fell 12.7% to $0.38 in pre-market trading.
  • Catalyst Biosciences Inc (NASDAQ:CBIO) fell 11.4% to $0.26 in pre-market trading. Catalyst Biosciences shares jumped around 24% on Tuesday after GC Biopharma signed an Asset Purchase Agreement with the company.
  • AMC Entertainment Holdings Inc (NYSE:AMC) shares fell 8.5% to $6.53 in pre-market trading after the company posted Q4 results. The company ended the quarter with available liquidity of $842.7 million and debt of $4.95 billion.

Now Read This: Top 5 Health Care Stocks That You May Want To Dump In Q1 2023

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment